The DOI matches its Crossref record; 88 of the 88 references it cites were found in a registry or an index.
The Therapeutic Potential of Naringenin: A Review of Clinical Trials
Open accessAbstract
Naringenin is a flavonoid belonging to flavanones subclass. It is widely distributed in several Citrus fruits, bergamot, tomatoes and other fruits, being also found in its glycosides form (mainly naringin). Several biological activities have been ascribed to this phytochemical, among them antioxidant, antitumor, antiviral, antibacterial, anti-inflammatory, antiadipogenic and cardioprotective effects. Nonetheless, most of the data reported have been obtained from in vitro or in vivo studies. Although some clinical studies have also been performed, the main focus is on naringenin bioavailability and cardioprotective action. In addition, these studies were done in compromised patients (i.e., hypercholesterolemic and overweight), with a dosage ranging between 600 and 800 μM/day, whereas the effect on healthy volunteers is still debatable. In fact, naringenin ability to improve endothelial function has been well-established. Indeed, the currently available data are very promising, but further research on pharmacokinetic and pharmacodynamic aspects is encouraged to improve both available production and delivery methods and to achieve feasible naringenin-based clinical formulations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Flavonoid intake and risk of chronic diseases
Knekt, P., Kumpulainen, J., Järvinen, R., Rissanen, H., Heliövaara, M., Reunanen, A., Hakulinen, T., & Aromaa, A. (2002) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/76.3.560 · Cited by 1,752
Flavonoid biosynthetic pathways in plants: Versatile targets for metabolic engineering
Nabavi, S. M., Šamec, D., Tomczyk, M., Milella, L., Russo, D., Habtemariam, S., Suntar, I., Rastrelli, L., Daglia, M., Xiao, J., et al. (2020) · Biotechnology Advances · doi:10.1016/j.biotechadv.2018.11.005 · Cited by 664
Baell, J. B. (2016) · Journal of Natural Products · doi:10.1021/acs.jnatprod.5b00947 · Cited by 539
Erlund, I., Meririnne, E., Alfthan, G., & Aro, A. (2001) · The Journal of Nutrition · doi:10.1093/jn/131.2.235 · Cited by 504
Kanaze, F. I., Bounartzi, M. I., Georgarakis, M., & Niopas, I. (2007) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1602543 · Cited by 368
De novo production of the flavonoid naringenin in engineered Saccharomyces cerevisiae
Koopman, F., Beekwilder, J., Crimi, B., van Houwelingen, A., Hall, R. D., Bosch, D., van Maris, A. J., Pronk, J. T., & Daran, J.-M. (2012) · Microbial Cell Factories · doi:10.1186/1475-2859-11-155 · Cited by 364
Beneficial effects of naringenin in liver diseases: Molecular mechanisms
Hernández-Aquino, E., & Muriel, P. (2018) · World Journal of Gastroenterology · doi:10.3748/wjg.v24.i16.1679 · Cited by 347
Nahmias, Y., Goldwasser, J., Casali, M., van Poll, D., Wakita, T., Chung, R. T., & Yarmush, M. L. (2008) · Hepatology · doi:10.1002/hep.22197 · Cited by 279
Pandey, R. P., Parajuli, P., Koffas, M. A. G., & Sohng, J. K. (2016) · Biotechnology Advances · doi:10.1016/j.biotechadv.2016.02.012 · Cited by 278
Combating oxidative stress disorders with citrus flavonoid: Naringenin
Zaidun, N. H., Thent, Z. C., & Latiff, A. A. (2018) · Life Sciences · doi:10.1016/j.lfs.2018.07.017 · Cited by 265
Cited by
Polyphenols: A concise overview on the chemistry, occurrence, and human health
Durazzo, A., Lucarini, M., Souto, E. B., Cicala, C., Caiazzo, E., Izzo, A. A., Novellino, E., & Santini, A. (2019) · Phytotherapy Research · doi:10.1002/ptr.6419 · Cited by 802
Zagoskina, N. V., Zubova, M. Y., Nechaeva, T. L., Kazantseva, V. V., Goncharuk, E. A., Katanskaya, V. M., Baranova, E. N., & Aksenova, M. A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241813874 · Cited by 423
Staphylococcus aureus Toxins: An Update on Their Pathogenic Properties and Potential Treatments
Ahmad-Mansour, N., Loubet, P., Pouget, C., Dunyach-Remy, C., Sotto, A., Lavigne, J.-P., & Molle, V. (2021) · Toxins · doi:10.3390/toxins13100677 · Cited by 386
Xu, S., Wu, B., Zhong, B., Lin, L., Ding, Y., Jin, X., Huang, Z., Lin, M., Wu, H., & Xu, D. (2021) · Bioengineered · doi:10.1080/21655979.2021.1995994 · Cited by 306
The Beauty of Biocatalysis: Sustainable Synthesis of Ingredients in Cosmetics
Heath, R. S., Ruscoe, R. E., & Turner, N. J. (2022) · Natural Product Reports · doi:10.1039/d1np00027f · Cited by 65
Metadata
- Authors
- Salehi, B., Fokou, P. V. T., Sharifi-Rad, M., Zucca, P., Pezzani, R., Martins, N., & Sharifi-Rad, J.
- Venue
- Pharmaceuticals
- Publisher
- MDPI AG
- Published
- 2019-01-10
- Volume
- 12
- Issue
- 1
- Pages
- 11
- ISSN
- 1424-8247 (ISSN-L)
- OpenAlex
- W2908708255
- Cited by
- 814
- References
- 88
- FWCI
- 46.61
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Therapeutic Potential of Naringenin: A Review of Clinical Trials. https://app.cochat.ai/papers/10.3390/ph12010011
- The paper
- Salehi, B., Fokou, P. V. T., Sharifi-Rad, M., Zucca, P., Pezzani, R., Martins, N., & Sharifi-Rad, J. (2019). The Therapeutic Potential of Naringenin: A Review of Clinical Trials. Pharmaceuticals. https://doi.org/10.3390/ph12010011
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.